Biotricity Inc reports results for the quarter ended in March - Earnings Summary

Biotricity

28/06/2024 22:01

* Biotricity Inc  BTCY.OQ  reported a quarterly adjusted
loss
of 47 cents​​ per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -54 cents.  The lone analyst forecast for the quarter was
for a loss of 36 cents per share. 
    * Revenue rose 15.9% to $3.18 million from a year ago;
analysts
expected $3.20 million. 
    * Biotricity Inc shares had fallen by 37.4% this quarter and
lost 19.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

This summary was machine generated from LSEG data June 28 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.36          -0.47          Missed
 Dec. 31 2023      -0.44          -0.34          Beat
 Sep. 30 2023      -0.34          -0.44          Missed
 Jun. 30 2023      -0.41          -0.41          Met